Ulland Investment Advisors LLC Cuts Stock Position in Intuitive Surgical, Inc. $ISRG

Ulland Investment Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 36.6% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 300 shares of the medical equipment provider’s stock after selling 173 shares during the period. Ulland Investment Advisors LLC’s holdings in Intuitive Surgical were worth $163,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ISRG. Brighton Jones LLC grew its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Wealthcare Advisory Partners LLC grew its position in shares of Intuitive Surgical by 26.4% during the first quarter. Wealthcare Advisory Partners LLC now owns 5,060 shares of the medical equipment provider’s stock valued at $2,506,000 after purchasing an additional 1,056 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Intuitive Surgical by 9.3% during the first quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $3,029,000 after purchasing an additional 518 shares in the last quarter. Simplicity Wealth LLC grew its position in shares of Intuitive Surgical by 108.9% during the first quarter. Simplicity Wealth LLC now owns 1,389 shares of the medical equipment provider’s stock valued at $688,000 after purchasing an additional 724 shares in the last quarter. Finally, Sanibel Captiva Trust Company Inc. grew its position in shares of Intuitive Surgical by 102.2% during the first quarter. Sanibel Captiva Trust Company Inc. now owns 1,880 shares of the medical equipment provider’s stock valued at $931,000 after purchasing an additional 950 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $443.76 on Friday. The company has a market cap of $159.08 billion, a P/E ratio of 61.89, a PEG ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a 50-day simple moving average of $459.75 and a two-hundred day simple moving average of $498.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.78 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ISRG. The Goldman Sachs Group cut their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Truist Financial lifted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $589.43.

Insider Activity

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.